ANN D. MONTGOMERY, District Judge.
This matter came before the undersigned United States District Court Judge on Defendants' Motion for Partial Dismissal [Docket No. 15]. For the reasons discussed below, Defendants' Motion is granted in part and denied in part.
The medical condition giving rise to this lawsuit is undeniably horrific. Plaintiff Lamar Hodges, Jr. ("Hodges") ingested Advil when he was 16 years old and suffered a severe adverse drug reaction known as Stevens-Johnson Syndrome ("SJS") / Toxic Epideral Necrolysis ("TEN"). Compl. [Docket No. 1] ¶ 8. Severe blistering affected 35% of his body, leaving essentially no skin on his face, neck, scalp, trunk, back, buttocks, arms, and legs.
Although Hodges' Complaint is comprised of 57 pages, Defendants argue that several claims are insufficiently pled. Specifically, Defendants move to dismiss the following claims:
(1) failure to warn (Counts I, VIII, IX); (2) manufacturing defect (Count III); (3) breach of express warranty (Count VII); (4) willful and wanton negligence (Count IX, in part); and (5) fraud-based claims (Counts IV, V, X, XI, XII and XIII).
Rule 12 of the Federal Rules of Civil Procedure provides that a party may move to dismiss a complaint for failure to state a claim upon which relief can be granted. Fed. R. Civ. P. 12(b)(6). In considering a motion to dismiss, the pleadings are construed in the light most favorable to the nonmoving party, and the facts alleged in the complaint must be taken as true.
Defendants argue that Hodges' manufacturing defect claim should be dismissed because Hodges does not plausibly alleged that the Advil he ingested departed from the drug's intended design. Hodges alleges that "[t]he product Advil manufactured, supplied, and/or sold by Defendants was defective in design or formulation in that when it left the hands of the manufacturers and/or sellers and (sic) was unreasonably dangerous in that its foreseeable risks exceeded the benefits associated with its design or formulation." Compl. ¶ 95. Hodges' broad allegations are insufficient to plead a manufacturing defect claim because he states only conclusions rather than facts that "raise a right to relief above the speculative level," and push claims "across the line from conceivable to plausible."
At oral argument, Hodges acknowledged that his manufacturing defect claim is in tension with his failure to warn, negligence and fraud-based claims. Nevertheless, counsel argued he included the defect claim to secure relevant discovery before conceding that such a claim was not feasible. This approach contracts federal pleading standards and cannot be allowed. Should discovery reveal information that allows Hodges to plead additional facts related to a possible manufacturing defect claim, he may seek leave to amend at that time. In the meantime, Hodges' manufacturing defect claim is dismissed without prejudice.
Defendant moves to dismiss Hodges' willful and wanton negligence claim for failure to allege sufficient facts showing Hodges was in a position of peril. To state a claim for willful and wanton negligence, a plaintiff must show that the defendant "fail[ed] to exercise ordinary care after discovering another in a position of peril."
Here, Hodges' specific allegations relating to his position of peril include his African-American race and his age of 16 years old. Hodges' Complaint includes a detailed history of incidents and circumstances that he alleges put Defendants on notice that certain populations, including young people and African Americans were more likely to suffer a SJS/TEN reaction from Advil.
The remaining claims Defendants seek to dismiss include Hodges' failure to warn (Counts I, VIII, IX), breach of express warranty (Count VII) and fraud-based claims (Counts IV, V, X, XI, XII, XIII). At the hearing, Hodges indicated that he may have additional facts to plead in support of these claims. Hodges also requested leave to amend his complaint in his response brief and at oral argument. Defendants oppose Hodges' request for leave to amend based on his failure to comply with Local Rule 15, which requires that a party file a copy of the proposed amended pleading, including a redlined version, with its motion. Minn. L.R. 15.1(b). Defendants also reserve the right to oppose Hodges' motion for leave to amend the Complaint.
Under these circumstances, the Court will defer ruling on Defendants' 12(b)(6) Motion on the remaining claims and allow Hodges seven (7) days to file a formal motion to amend. Hodges motion to amend must comply with the Local Rules and, as in the normal course, Defendants will have the opportunity to oppose the motion. Once the motion to amend is resolved, the Court will reconsider Defendants 12(b)(6) Motion to Dismiss the remaining claims.
Based upon all the files, records, and proceedings herein,